Trial Profile
Long-term study of HFT-290 in patients with chronic pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 20 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information; JapicCTI101348)
- 18 Mar 2013 New trial record